Why Altimmune (ALT) Stock is Down More Than 40% Today?
The shares of Altimmune Inc. (NASDAQ: ALT) were down by -43.03% to $11.61 at the start of the trading on Wednesday despite the company reporting encouraging clinical study results. ALT closed Tuesday’s session at $20.38, down -0.39%. ALT has announced what? As a result of its 12-week Phase 1b study evaluating pemvidutide1, Altimmune (ALT) today […]